–July 5, 2005
Pfizer Inc. said it conducted a review of all reported incidences of vision loss events after patients had taken Viagra, concluding there was no evidence of increased risk of vision loss, but the company is working with federal regulators to update the drug’s label to reflect the reports.
Last month, the FDA said it had received 38 reports of blindness caused by a condition called non-arteritic anterior ischemic optic neuropathy, or NAION, among Viagra users. The FDA concluded no casual relationship between Viagra and NAION has been established, but the drug company has agreed to include the reports exist on Viagra labeling to inform physicians and patients of the possible drug effects.
For more information on Viagra and vision loss, please contact us to confer with an attorney.
